People living with respiratory disease require a significant amount of support, guidance and intervention to manage their condition effectively. These interventions should be delivered by clinicians with an appropriate level of expertise in this field.

Now is the time to make MART moves for asthma. 

Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers. 

Inhalation is the main route for administration of drugs for conditions such as asthma or chronic obstructive pulmonary disease. The advantage of administering drugs by inhaler is that drugs are delivered directly to the site of action within the airways.

Language can play a big barrier in healthcare delivery – for example, by preventing people accessing healthcare in an effectively and timely way, preventing people understand what they need to do to support their own self-management, or by preventing people from understanding their treatment and

These templates are only available to EMIS and TPP users – they are not available to MicroTest and Vision users.

There are no mandatory training requirements for healthcare professionals delivering respiratory care and the quality of care and patient pathways are variable throughout the country depending on the knowledge, skills, competence and confidence of those delivering care.

Patients with respiratory disease deserve equal access to early and accurate diagnosis, high standards of care, delivered by practitioners with suitable training and experience.

Noel Baxter PCRS Policy Lead and Tracey Lonergan PCRS Policy Coordinator.